2023, Disease and PET Scan - Diagnostic Imaging Brief

PET links depressive symptoms to Alzheimer’s brain pathology

AuntMinnie

APRIL 10, 2025

Columbia University researchers in New York City have reported that worsening depression in older adults is related to higher levels of Alzheimers disease pathology, specifically the accumulation of tau protein. The study was published April 9 in the American Journal of Geriatric Psychiatry. The full study can be found here.

PET Scan

PET Scan Disease Education Clinic

PET reveals patient responses to new Alzheimer’s disease drug

AuntMinnie

OCTOBER 27, 2023

Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. The full report is available here.

Disease

Disease PET Scan Clinic Diagnose

Metabolic MRI technique shows promise in Alzheimer’s patients

AuntMinnie

APRIL 8, 2025

Deuterium metabolic imaging (DMI) was highly aligned with F-18 FDG-PET -- a cornerstone of dementia diagnostics -- in patients with Alzheimer's disease in a study published April 8 in Radiology. Given that PET scans are more expensive and expose patients to small amounts of radiation, DMI is being explored as an alternative.

MRI

MRI Disease PET Scan Clinic

Evidence grows for use of amyloid PET in China

AuntMinnie

FEBRUARY 12, 2024

Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University. “In

PET Scan

PET Scan Diagnose Disease Radiopharmaceuticals

Midlife belly fat linked to increased Alzheimer's risk

AuntMinnie

NOVEMBER 20, 2023

People with higher amounts of visceral abdominal fat in midlife may be at increased risk of Alzheimer's disease, according to research to be presented at the upcoming RSNA meeting. A subset of 32 patients underwent PET imaging to identify any amyloid plaque and tau tangles that would indicate the development of Alzheimer's disease.

Disease

Disease PET Scan MRI Imaging

FAPI-PET shows promise in patients with lung cancer

AuntMinnie

APRIL 15, 2024

A group at University Hospital Heidelberg in Germany assessed the approach in 19 patients referred by their treating physicians because of inconclusive lung cancer findings on CT and F-18 FDG-PET. FAPI-PET either confirmed or ruled out the disease in all cases, the group found.

Nuclear Medicine

Nuclear Medicine PET Scan Hospital Clinic

Research Spotlight: Validating an MRI Biomarker for Early Onset Alzheimer’s Disease

Imaging Technology

OCTOBER 19, 2023

Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort.

Disease

Disease MRI Magnetic Resonance Imaging PET Scan

Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

Imaging Technology

OCTOBER 20, 2023

milla1cf Fri, 10/20/2023 - 18:30 October 20, 2023 — Meilleur Technologies, Inc. Amyloid plaques are a hallmark of several neurodegenerative diseases, including Alzheimer’s Disease (AD). The collaboration is focused on using [F-18]NAV-4694 as an imaging biomarker in ADNI4’s neurodegenerative disease research.

Disease

Disease PET Scan Pharmaceutical Imaging

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans.

Nuclear Medicine

Nuclear Medicine Radiopharmaceuticals Radiation Health Science

Recurrent Brain Trauma May Increase Alzheimer’s Risk

Imaging Technology

MAY 22, 2023

milla1cf Mon, 05/22/2023 - 13:16 May 22, 2023 — New research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer’s disease.

Disease

Disease PET Scan Radiology MRI

New Guidance for Amyloid and Tau PET Imaging Released

Imaging Technology

JANUARY 30, 2025

30, 2025 Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,

Nuclear Medicine

Nuclear Medicine Imaging Patient Care Disease

GE HealthCare and Axim Life Isotopes South Africa (ALISA) Collaborate to Expand Access to Molecular Imaging in South Africa and Drive Precision Care

Imaging Technology

APRIL 28, 2023

ALISA), a joint venture between Life Healthcare and the AXIM Group of Companies, to expand provision of molecular imaging in South Africa with the delivery of two Cyclotrons, which produce radioisotopes enabling the production of tracing agents used in molecular imaging scans. It can allow early and precise diagnosis.

Healthcare

Healthcare Healthcare Radiopharmaceuticals PET Scan

Ultra-High Resolution Brain PET Scanner Visualizes and Quantifies Brainstem Nuclei for the First Time

Imaging Technology

JUNE 24, 2023

mtaschetta-millane Sat, 06/24/2023 - 17:00 June 24, 2023 — A new ultra-high resolution (UHR) brain PET scanner may have the ability to characterize previously indistinguishable brain regions that are known to be involved in Alzheimer’s disease , depressive disorders, visual attention disorders, tinnitus, and other conditions.

Nuclear Medicine

Nuclear Medicine Radiation Science PET Scan Disease

Renowned Radiation Oncologist Joins NYU Langone’s Perlmutter Cancer Center as Vice Chair for Academic and Faculty Affairs, Director of Brachytherapy

Imaging Technology

SEPTEMBER 12, 2023

milla1cf Tue, 09/12/2023 - 13:16 September 12, 2023 — Michael J. In addition to his other roles, Dr. Zelefsky will serve as a professor in the department and Genitourinary Cancer Disease Management Group leader. For more information: [link] Tuesday, September 12, 2023 - 13:16

Radiation

Radiation Radiation Oncology PET Scan Medical

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

Imaging Technology

MAY 31, 2023

milla1cf Wed, 05/31/2023 - 20:52 May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing Effortless Recon DL portfolio. Deep learning–based time-of-flight (ToF) image enhancement of non-ToF PET scans.

Nuclear Medicine

Nuclear Medicine Healthcare Healthcare IT

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. Results demonstrated high detection rates (% positive PET scans) even at low PSA levels.

Diagnostic

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans.

Nuclear Medicine

Nuclear Medicine Radiopharmaceuticals Radiation Health Science

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

Imaging Technology

MAY 2, 2023

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 18F-rhPSMA-7.3 Gauden , D.Phil.,

Diagnostic

Diagnostic Radiopharmaceuticals Imaging Radiation

Meet the Minnies 2024 semifinal candidates

AuntMinnie

OCTOBER 2, 2024

tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PET scans predict patient response to Pluvicto.

Digital Imaging and Communications in Medicine

Digital Imaging and Communications in Medicine X-ray MRI Hospital

Unlocking the potential of imaging in Alzheimer’s disease care

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease

Disease Imaging Medicare PET Scan

PET Scans May Predict Parkinson’s Disease and Lewy Body Dementia in At-risk Individuals

Imaging Technology

NOVEMBER 8, 2023

milla1cf Wed, 11/08/2023 - 13:01 November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission tomography (PET) scans of the heart may identify people who will go on to develop Parkinson’s disease or Lewy body dementia among those at-risk for these diseases.

PET Scan

PET Scan Disease Diagnose Clinic

Top Imaging News of 2023

Vesta Teleradiology

DECEMBER 29, 2023

As we bid adieu to the final moments of 2023, it’s a great time to reflect on advancements and studies that have redefined the world of imaging this year. Check out our previous articles highlighting the impact that ChatGPT and Bard have made in 2023.

Imaging

Imaging Radiation PET Scan Teleradiology

AI Could Help Doctors Diagnose Lung Cancer Earlier

Imaging Technology

MAY 1, 2023

milla1cf Mon, 05/01/2023 - 17:03 May 1, 2023 — Artificial intelligence ( AI ) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research , London, and Imperial College London.

Diagnose

Diagnose Disease Clinic PET Scan

Updated Appropriate Use Criteria for Amyloid and Tau PET Imaging Released

Imaging Technology

JANUARY 14, 2025

8, 2025 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8,

Nuclear Medicine

Nuclear Medicine Imaging Patient Care PET Scan

Diagnostic Imaging Brief

PET links depressive symptoms to Alzheimer’s brain pathology

PET reveals patient responses to new Alzheimer’s disease drug

Trending Sources

Metabolic MRI technique shows promise in Alzheimer’s patients

Evidence grows for use of amyloid PET in China

Midlife belly fat linked to increased Alzheimer's risk

FAPI-PET shows promise in patients with lung cancer

Research Spotlight: Validating an MRI Biomarker for Early Onset Alzheimer’s Disease

Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

The rise of theranostics: Part 1 -- Gaining momentum

Recurrent Brain Trauma May Increase Alzheimer’s Risk

New Guidance for Amyloid and Tau PET Imaging Released

GE HealthCare and Axim Life Isotopes South Africa (ALISA) Collaborate to Expand Access to Molecular Imaging in South Africa and Drive Precision Care

Ultra-High Resolution Brain PET Scanner Visualizes and Quantifies Brainstem Nuclei for the First Time

Renowned Radiation Oncologist Joins NYU Langone’s Perlmutter Cancer Center as Vice Chair for Academic and Faculty Affairs, Director of Brachytherapy

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

The rise of theranostics: Part 1 -- Gaining momentum

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

Meet the Minnies 2024 semifinal candidates

Unlocking the potential of imaging in Alzheimer’s disease care

PET Scans May Predict Parkinson’s Disease and Lewy Body Dementia in At-risk Individuals

Top Imaging News of 2023

AI Could Help Doctors Diagnose Lung Cancer Earlier

Updated Appropriate Use Criteria for Amyloid and Tau PET Imaging Released

Stay Connected